165 related articles for article (PubMed ID: 27369688)
1. [Duloxetine-Induced Hypertension: A Case Report].
Mermi O; Atmaca M
Turk Psikiyatri Derg; 2016; 27(1):67-9. PubMed ID: 27369688
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine-induced rapid eye movement sleep behavior disorder: a case report.
Tan L; Zhou J; Yang L; Ren R; Zhang Y; Li T; Tang X
BMC Psychiatry; 2017 Nov; 17(1):372. PubMed ID: 29162053
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
[TBL] [Abstract][Full Text] [Related]
4. Cervical Spinal Cord Stimulation with Concomitant Serotonin Norepinephrine Reuptake Inhibitor Therapy Leading to the Serotonin Syndrome.
Dizdarevic A; Bremer N
Pain Med; 2017 Jun; 18(6):1199-1202. PubMed ID: 28057811
[No Abstract] [Full Text] [Related]
5. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
6. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors.
Biglia N; Bounous VE; Susini T; Pecchio S; Sgro LG; Tuninetti V; Torta R
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26936232
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
9. [Duloxetine Associated Galactorrhea and Hyperprolactinemia: A Case Report].
Özkan HM
Turk Psikiyatri Derg; 2020; 31(4):294-296. PubMed ID: 33454942
[TBL] [Abstract][Full Text] [Related]
10. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
Himmighoffen H; Seifritz E; Boeker H
Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
[No Abstract] [Full Text] [Related]
11. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
[TBL] [Abstract][Full Text] [Related]
12. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.
Härmark L; van Puijenbroek E; van Grootheest K
Eur J Clin Pharmacol; 2013 Feb; 69(2):209-15. PubMed ID: 22688722
[TBL] [Abstract][Full Text] [Related]
13. Infant Exposure to Methylphenidate and Duloxetine During Lactation.
Collin-Lévesque L; El-Ghaddaf Y; Genest M; Jutras M; Leclair G; Weisskopf E; Panchaud A; Ferreira E
Breastfeed Med; 2018 Apr; 13(3):221-225. PubMed ID: 29485905
[TBL] [Abstract][Full Text] [Related]
14. [Duloxetine reduces pain and depression].
Krankenpfl J; 2004; 42(7-10):246-7. PubMed ID: 15675408
[No Abstract] [Full Text] [Related]
15. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
[TBL] [Abstract][Full Text] [Related]
16. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants May Make for Depressing Surgery.
Oberg TJ; Eftekhari K; Anderson RL
Ophthalmic Plast Reconstr Surg; 2015; 31(4):334. PubMed ID: 26164037
[No Abstract] [Full Text] [Related]
18. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
Stovall R; Brahm NC; Crosby KM
Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine: clinical pharmacokinetics and drug interactions.
Knadler MP; Lobo E; Chappell J; Bergstrom R
Clin Pharmacokinet; 2011 May; 50(5):281-94. PubMed ID: 21366359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
